Luis M De La Maza

Title(s)Professor, Pathology
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(949) 824-7450
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Center for Biologically Inspired Nano-scaffolds for Mitigating Chlamydia trachomatis Pathogenesis
    NIH U19AI144184Aug 8, 2019 - Jul 31, 2024
    Role: Co-Principal Investigator
    Trapping membrane proteins with adjuvant-carrying amphipols for vaccine formulati
    NIH R01AI092129Sep 1, 2011 - Aug 31, 2016
    Role: Principal Investigator
    Evaluation of a subunit Chlamydia trachomatis vaccine in Rhesus Macaques
    NIH R56AI093953Sep 1, 2011 - Aug 31, 2013
    Role: Principal Investigator
    Scanning Chlamydia proteome for vaccine antigens
    NIH R42AI072847Apr 15, 2007 - Jun 30, 2012
    Role: Principal Investigator
    Scanning Chlamydia proteome for vaccine antigens
    NIH R41AI072847Apr 15, 2007 - Sep 16, 2009
    Role: Principal Investigator
    Recombinant C. trachomatis vaccine
    NIH R01AI067888Mar 16, 2007 - Feb 28, 2013
    Role: Principal Investigator
    Immunopathology of Tubal Infertility
    NIH R01AI032248Jan 1, 1993 - Jan 31, 2010
    Role: Principal Investigator
    RECOMBINANT POLYTYPIC CHLAMYDIA VACCINE
    NIH R01AI026807Sep 1, 1989 - Aug 31, 1993
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go? Expert Rev Vaccines. 2021 Apr; 20(4):421-435. de la Maza LM, Darville TL, Pal S. PMID: 33682583.
      View in: PubMed   Mentions:    Fields:    
    2. A primary Chlamydia trachomatis genital infection of rhesus macaques identifies new immunodominant B-cell antigens. PLoS One. 2021; 16(4):e0250317. Randall A, Teng A, Liang X, Pal S, Tarantal AF, Fike J, Barry PA, de la Maza LM. PMID: 33886668.
      View in: PubMed   Mentions:    Fields:    
    3. Vaccination with the recombinant major outer membrane protein elicits long-term protection in mice against vaginal shedding and infertility following a Chlamydia muridarum genital challenge. NPJ Vaccines. 2020; 5:90. Pal S, Cruz-Fisher MI, Cheng C, Carmichael JR, Tifrea DF, Tatarenkova O, de la Maza LM. PMID: 33083025.
      View in: PubMed   Mentions:
    4. Induction of protection in mice against a respiratory challenge by a vaccine formulated with exosomes isolated from Chlamydia muridarum infected cells. NPJ Vaccines. 2020; 5:87. Pal S, Mirzakhanyan Y, Gershon P, Tifrea DF, de la Maza LM. PMID: 33014435.
      View in: PubMed   Mentions:
    5. Protection against a chlamydial respiratory challenge by a chimeric vaccine formulated with the Chlamydia muridarum major outer membrane protein variable domains using the Neisseria lactamica porin B as a scaffold. NPJ Vaccines. 2020; 5:37. Tifrea DF, Pal S, Fairman J, Massari P, de la Maza LM. PMID: 32411400.
      View in: PubMed   Mentions:
    6. Protection against a chlamydial respiratory challenge by a chimeric vaccine formulated with the Chlamydia muridarum major outer membrane protein variable domains using the Neisseria lactamica porin B as a scaffold. NPJ Vaccines. 2020 May 08; 5(1):37. Tifrea DF, Pal S, Fairman J, Massari P, de la Maza LM. PMID: 33574319.
      View in: PubMed   Mentions:
    7. Improved protection against Chlamydia muridarum using the native major outer membrane protein trapped in Resiquimod-carrying amphipols and effects in protection with addition of a Th1 (CpG-1826) and a Th2 (Montanide ISA 720) adjuvant. Vaccine. 2020 06 09; 38(28):4412-4422. Tifrea DF, Pal S, le Bon C, Cocco MJ, Zoonens M, de la Maza LM. PMID: 32386746.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    8. Immune response against Chlamydia trachomatis via toll-like receptors is negatively regulated by SIGIRR. PLoS One. 2020; 15(3):e0230718. Al-Kuhlani M, Lambert G, Pal S, de la Maza L, Ojcius DM. PMID: 32210474.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    9. Protection of outbred mice against a vaginal challenge by a Chlamydia trachomatis serovar E recombinant major outer membrane protein vaccine is dependent on phosphate substitution in the adjuvant. Hum Vaccin Immunother. 2020 10 02; 16(10):2537-2547. Pal S, Ausar SF, Tifrea DF, Cheng C, Gallichan S, Sanchez V, de la Maza LM, Visan L. PMID: 32118511.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    10. A Recombinant Chlamydia trachomatis MOMP Vaccine Elicits Cross-serogroup Protection in Mice Against Vaginal Shedding and Infertility. J Infect Dis. 2020 01 02; 221(2):191-200. Tifrea DF, Pal S, de la Maza LM. PMID: 31504647.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    11. Characterization of the Horizontal and Vertical Sexual Transmission of Chlamydia Genital Infections in a New Mouse Model. Infect Immun. 2019 07; 87(7). Pal S, Tifrea DF, de la Maza LM. PMID: 30833332.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    12. Co-delivery of amphipol-conjugated adjuvant with antigen, and adjuvant combinations, enhance immune protection elicited by a membrane protein-based vaccine against a mucosal challenge with Chlamydia. Vaccine. 2018 10 29; 36(45):6640-6649. Tifrea DF, Pal S, Le Bon C, Giusti F, Popot JL, Cocco MJ, Zoonens M, de la Maza LM. PMID: 30293763.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    13. Transcervical Inoculation with Chlamydia trachomatis Induces Infertility in HLA-DR4 Transgenic and Wild-Type Mice. Infect Immun. 2018 01; 86(1). Pal S, Tifrea DF, Zhong G, de la Maza LM. PMID: 29038126.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    14. National Institute of Allergy and Infectious Diseases workshop report: "Chlamydia vaccines: The way forward". Vaccine. 2019 11 28; 37(50):7346-7354. Zhong G, Brunham RC, de la Maza LM, Darville T, Deal C. PMID: 29097007.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    15. Genome-wide profiling of humoral immunity and pathogen genes under selection identifies immune evasion tactics of Chlamydia trachomatis during ocular infection. Sci Rep. 2017 08 29; 7(1):9634. Pickering H, Teng A, Faal N, Joof H, Makalo P, Cassama E, Nabicassa M, Last AR, Burr SE, Rowland-Jones SL, Thomson NR, Roberts CH, Mabey DCW, Bailey RL, Hayward RD, de la Maza LM, Holland MJ. PMID: 28851925.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    16. In Situ Vaccination after Accelerated Hypofractionated Radiation and Surgery in a Mesothelioma Mouse Model. Clin Cancer Res. 2017 Sep 15; 23(18):5502-5513. De La Maza L, Wu M, Wu L, Yun H, Zhao Y, Cattral M, McCart A, Cho BJ, de Perrot M. PMID: 28606922.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    17. Update on Chlamydia trachomatis Vaccinology. Clin Vaccine Immunol. 2017 Apr; 24(4). de la Maza LM, Zhong G, Brunham RC. PMID: 28228394.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    18. Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge. Vaccine. 2017 05 02; 35(19):2543-2549. Pal S, Favaroni A, Tifrea DF, Hanisch PT, Luczak SET, Hegemann JH, de la Maza LM. PMID: 28385608.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    19. The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge. Vaccine. 2017 03 23; 35(13):1705-1711. Pal S, Tifrea DF, Follmann F, Andersen P, de la Maza LM. PMID: 28238632.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    20. Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis. Hum Vaccin Immunother. 2016 09; 12(9):2341-50. Visan L, Sanchez V, Kania M, de Montfort A, de la Maza LM, Ausar SF. PMID: 27104338.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    21. Computational modeling of TC0583 as a putative component of the Chlamydia muridarum V-type ATP synthase complex and assessment of its protective capabilities as a vaccine antigen. Microbes Infect. 2016 Apr; 18(4):245-53. Tifrea DF, Barta ML, Pal S, Hefty PS, de la Maza LM. PMID: 26706820.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    22. A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge. Immunology. 2015 Nov; 146(3):432-43. Pal S, Tatarenkova OV, de la Maza LM. PMID: 26423798.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    23. Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model. Oncotarget. 2015 May 20; 6(14):12468-80. Wu L, Wu MO, De la Maza L, Yun Z, Yu J, Zhao Y, Cho J, de Perrot M. PMID: 25980578.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    24. Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma. Cancer Immunol Immunother. 2014 Dec; 63(12):1285-96. Wu L, Yun Z, Tagawa T, De la Maza L, Wu MO, Yu J, Zhao Y, de Perrot M. PMID: 25183171.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    25. Long-term stability of a vaccine formulated with the amphipol-trapped major outer membrane protein from Chlamydia trachomatis. J Membr Biol. 2014 Oct; 247(9-10):1053-65. Feinstein HE, Tifrea D, Sun G, Popot JL, de la Maza LM, Cocco MJ. PMID: 24942817.
      View in: PubMed   Mentions: 5     Fields:    Translation:Cells
    26. Whole genome identification of C. trachomatis immunodominant antigens after genital tract infections and effect of antibiotic treatment of pigtailed macaques. J Proteomics. 2014 Aug 28; 108:99-109. Patton DL, Teng A, Randall A, Liang X, Felgner PL, de la Maza LM. PMID: 24862987.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    27. Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum. J Immunol. 2014 Jun 01; 192(11):5201-13. Tifrea DF, Pal S, Popot JL, Cocco MJ, de la Maza LM. PMID: 24778450.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    28. TRAIL-R1 is a negative regulator of pro-inflammatory responses and modulates long-term sequelae resulting from Chlamydia trachomatis infections in humans. PLoS One. 2014; 9(4):e93939. Al-Kuhlani M, Rothschild J, Rothchild J, Pal S, de la Maza LM, Ouburg S, Morré SA, Dean D, Ojcius DM. PMID: 24695582.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    29. A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge. Microbes Infect. 2014 Mar; 16(3):244-52. Cheng C, Pal S, Tifrea D, Jia Z, de la Maza LM. PMID: 24291713.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    30. Assessment of the role in protection and pathogenesis of the Chlamydia muridarum V-type ATP synthase subunit A (AtpA) (TC0582). Microbes Infect. 2014 Feb; 16(2):123-133. Cheng C, Jain P, Pal S, Tifrea D, Sun G, Teng AA, Liang X, Felgner PL, de la Maza LM. PMID: 24161793.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    31. Vaccination with major outer membrane protein proteosomes elicits protection in mice against a Chlamydia respiratory challenge. Microbes Infect. 2013 Nov; 15(13):920-7. Tifrea DF, Pal S, Toussi DN, Massari P, de la Maza LM. PMID: 23999313.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCellsPHPublic Health
    32. A 3-dimensional trimeric ß-barrel model for Chlamydia MOMP contains conserved and novel elements of Gram-negative bacterial porins. PLoS One. 2013; 8(7):e68934. Feher VA, Randall A, Baldi P, Bush RM, de la Maza LM, Amaro RE. PMID: 23935908.
      View in: PubMed   Mentions: 16     Fields:    Translation:Cells
    33. Mechanism of T-cell mediated protection in newborn mice against a Chlamydia infection. Microbes Infect. 2013 Jul-Aug; 15(8-9):607-14. Pal S, de la Maza LM. PMID: 23644176.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    34. Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis. Infect Immun. 2013 May; 81(5):1741-50. Tifrea DF, Ralli-Jain P, Pal S, de la Maza LM. PMID: 23478318.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCellsPHPublic Health
    35. Differences in infectivity and induction of infertility: a comparative study of Chlamydia trachomatis strains in the murine model. Microbes Infect. 2013 Mar; 15(3):219-29. Carmichael JR, Tifrea D, Pal S, de la Maza LM. PMID: 23287699.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    36. Toll-like receptor 2-dependent activity of native major outer membrane protein proteosomes of Chlamydia trachomatis. Infect Immun. 2013 Jan; 81(1):303-10. Massari P, Toussi DN, Tifrea DF, de la Maza LM. PMID: 23132491.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    37. Proteomic identification of immunodominant chlamydial antigens in a mouse model. J Proteomics. 2012 Dec 21; 77:176-86. Teng A, Cruz-Fisher MI, Cheng C, Pal S, Sun G, Ralli-Jain P, Molina DM, Felgner PL, Liang X, de la Maza LM. PMID: 22959960.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCellsPHPublic Health
    38. A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors. Vaccine. 2011 Sep 02; 29(38):6641-9. Cheng C, Jain P, Bettahi I, Pal S, Tifrea D, de la Maza LM. PMID: 21742006.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCellsPHPublic Health
    39. Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine. Vaccine. 2011 Jul 18; 29(32):5276-83. Carmichael JR, Pal S, Tifrea D, de la Maza LM. PMID: 21609745.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    40. Amphipols stabilize the Chlamydia major outer membrane protein and enhance its protective ability as a vaccine. Vaccine. 2011 Jun 20; 29(28):4623-31. Tifrea DF, Sun G, Pal S, Zardeneta G, Cocco MJ, Popot JL, de la Maza LM. PMID: 21550371.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCellsPHPublic Health
    41. Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model. Vaccine. 2011 Apr 18; 29(18):3456-64. Cheng C, Pal S, Bettahi I, Oxford KL, Barry PA, de la Maza LM. PMID: 21376796.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCellsPHPublic Health
    42. Induction of protection in mice against a respiratory challenge by a vaccine formulated with the Chlamydia major outer membrane protein adjuvanted with IC31®. Vaccine. 2011 Mar 16; 29(13):2437-43. Cheng C, Cruz-Fisher MI, Tifrea D, Pal S, Wizel B, de la Maza LM. PMID: 21276442.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    43. Identification of immunodominant antigens by probing a whole Chlamydia trachomatis open reading frame proteome microarray using sera from immunized mice. Infect Immun. 2011 Jan; 79(1):246-57. Cruz-Fisher MI, Cheng C, Sun G, Pal S, Teng A, Molina DM, Kayala MA, Vigil A, Baldi P, Felgner PL, Liang X, de la Maza LM. PMID: 20956570.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    44. A new murine model for testing vaccines against genital Chlamydia trachomatis infections in males. Vaccine. 2010 Nov 10; 28(48):7606-12. Pal S, Sarcon AK, de la Maza LM. PMID: 20920574.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    45. Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization. Vaccine. 2010 Nov 10; 28(48):7659-66. Ralli-Jain P, Tifrea D, Cheng C, Pal S, de la Maza LM. PMID: 20875490.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    46. Maternal immunity partially protects newborn mice against a Chlamydia trachomatis intranasal challenge. J Reprod Immunol. 2010 Nov; 86(2):151-7. Pal S, Tatarenkova O, de la Maza LM. PMID: 20554327.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    47. Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae. Int J Antimicrob Agents. 2010 Aug; 36(2):145-50. Chu H, Slepenkin A, Elofsson M, Keyser P, de la Maza LM, Peterson EM. PMID: 20605703.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    48. Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarrays. Vaccine. 2010 Apr 09; 28(17):3014-24. Molina DM, Pal S, Kayala MA, Teng A, Kim PJ, Baldi P, Felgner PL, Liang X, de la Maza LM. PMID: 20044059.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCells
    49. C3H male mice with severe combined immunodeficiency cannot clear a urethral infection with a human serovar of Chlamydia trachomatis. Infect Immun. 2009 Dec; 77(12):5602-7. Pal S, Sarcon AK, de la Maza LM. PMID: 19805533.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    50. Biophysical and stabilization studies of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein. Mol Pharm. 2009 Sep-Oct; 6(5):1553-61. Cai S, He F, Samra HS, de la Maza LM, Bottazzi ME, Joshi SB, Middaugh CR. PMID: 19650664.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    51. Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin. Vaccine. 2009 Oct 19; 27(44):6239-46. Cheng C, Bettahi I, Cruz-Fisher MI, Pal S, Jain P, Jia Z, Holmgren J, Harandi AM, de la Maza LM. PMID: 19686693.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    52. Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine. J Immunol. 2009 Jun 15; 182(12):8063-70. Kari L, Whitmire WM, Crane DD, Reveneau N, Carlson JH, Goheen MM, Peterson EM, Pal S, de la Maza LM, Caldwell HD. PMID: 19494332.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansAnimalsCells
    53. Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein. Vaccine. 2009 Aug 06; 27(36):5020-5. Sun G, Pal S, Weiland J, Peterson EM, de la Maza LM. PMID: 19446590.
      View in: PubMed   Mentions: 39     Fields:    Translation:AnimalsCells
    54. Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity. 2008 Oct 17; 29(4):602-14. Matheu MP, Beeton C, Garcia A, Chi V, Rangaraju S, Safrina O, Monaghan K, Uemura MI, Li D, Pal S, de la Maza LM, Monuki E, Flügel A, Pennington MW, Parker I, Chandy KG, Cahalan MD. PMID: 18835197.
      View in: PubMed   Mentions: 106     Fields:    Translation:AnimalsCells
    55. Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein. Infect Immun. 2008 Dec; 76(12):5581-7. Pal S, Bravo J, Peterson EM, de la Maza LM. PMID: 18809664.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    56. Structural and functional analyses of the major outer membrane protein of Chlamydia trachomatis. J Bacteriol. 2007 Sep; 189(17):6222-35. Sun G, Pal S, Sarcon AK, Kim S, Sugawara E, Nikaido H, Cocco MJ, Peterson EM, de la Maza LM. PMID: 17601785.
      View in: PubMed   Mentions: 44     Fields:    Translation:Cells
    57. Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron. Infect Immun. 2007 Jul; 75(7):3478-89. Slepenkin A, Enquist PA, Hägglund U, de la Maza LM, Elofsson M, Peterson EM. PMID: 17470544.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    58. Role of matrix metalloproteinase-7 in the modulation of a Chlamydia trachomatis infection. Immunology. 2006 Feb; 117(2):213-9. Pal S, Schmidt AP, Peterson EM, Wilson CL, de la Maza LM. PMID: 16423057.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    59. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect Immun. 2005 Dec; 73(12):8153-60. Pal S, Peterson EM, de la Maza LM. PMID: 16299310.
      View in: PubMed   Mentions: 92     Fields:    Translation:AnimalsCells
    60. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge. Vaccine. 2006 Feb 06; 24(6):766-75. Pal S, Peterson EM, Rappuoli R, Ratti G, de la Maza LM. PMID: 16199110.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    61. Vaccination of newborn mice induces a strong protective immune response against respiratory and genital challenges with Chlamydia trachomatis. Vaccine. 2005 Nov 16; 23(46-47):5351-8. Pal S, Peterson EM, de la Maza LM. PMID: 16085340.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCellsPHPublic Health
    62. Up-regulation of the JAK/STAT1 signal pathway during Chlamydia trachomatis infection. J Immunol. 2005 Jun 01; 174(11):7186-93. Lad SP, Fukuda EY, Li J, de la Maza LM, Li E. PMID: 15905563.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    63. Characterization of the disulfide bonds and free cysteine residues of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein. Biochemistry. 2005 Apr 26; 44(16):6250-6. Yen TY, Pal S, de la Maza LM. PMID: 15835913.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    64. Interaction between components of the type III secretion system of Chlamydiaceae. J Bacteriol. 2005 Jan; 187(2):473-9. Slepenkin A, de la Maza LM, Peterson EM. PMID: 15629918.
      View in: PubMed   Mentions: 20     Fields:    Translation:Cells
    65. New murine model for the study of Chlamydia trachomatis genitourinary tract infections in males. Infect Immun. 2004 Jul; 72(7):4210-6. Pal S, Peterson EM, de la Maza LM. PMID: 15213165.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    66. Induction of protective immunity against a Chlamydia trachomatis genital infection in three genetically distinct strains of mice. Immunology. 2003 Nov; 110(3):368-75. Pal S, Peterson EM, de la Maza LM. PMID: 14632665.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    67. Temporal expression of type III secretion genes of Chlamydia pneumoniae. Infect Immun. 2003 May; 71(5):2555-62. Slepenkin A, Motin V, de la Maza LM, Peterson EM. PMID: 12704128.
      View in: PubMed   Mentions: 21     Fields:    Translation:Cells
    68. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge. Vaccine. 2003 Mar 28; 21(13-14):1455-65. Pal S, Luke CJ, Barbour AG, Peterson EM, de la Maza LM. PMID: 12615442.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCellsPHPublic Health
    69. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge. Infect Immun. 2002 Sep; 70(9):4812-7. Pal S, Davis HL, Peterson EM, de la Maza LM. PMID: 12183524.
      View in: PubMed   Mentions: 30     Fields:    Translation:AnimalsCellsPHPublic Health
    70. Prediction of the membrane-spanning beta-strands of the major outer membrane protein of Chlamydia. Protein Sci. 2002 Jul; 11(7):1854-61. Rodríguez-Marañón MJ, Bush RM, Peterson EM, Schirmer T, de la Maza LM. PMID: 12070338.
      View in: PubMed   Mentions: 27     Fields:    Translation:Cells
    71. Vaccines for Chlamydia trachomatis infections. Curr Opin Investig Drugs. 2002 Jul; 3(7):980-6. de la Maza LM, Peterson EM. PMID: 12186275.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    72. Inclusion fluorescent-antibody test as a screening assay for detection of antibodies to Chlamydia pneumoniae. Clin Diagn Lab Immunol. 2002 May; 9(3):562-7. Tapia O, Slepenkin A, Sevrioukov E, Hamor K, de la Maza LM, Peterson EM. PMID: 11986260.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    73. Comparison of two commercially available selective media to screen for vancomycin-resistant enterococci. Am J Clin Pathol. 2002 Jan; 117(1):152-5. Shigei J, Tan G, Shiao A, de la Maza LM, Peterson EM. PMID: 11789720.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    Luis's Networks
    Concepts (310)
    Derived automatically from this person's publications.
    _
    Co-Authors (12)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _